Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia
1. Glucagon-like peptide-1 receptor agonists (GLP-1RA) in combination with progestins are significantly more effective at reducing endometrial cancer (EC) risk ...



